Tedizolid-phosphate-TR-701FA-DataSheet-生命科學(xué)試劑-MedChemExpress_第1頁(yè)
Tedizolid-phosphate-TR-701FA-DataSheet-生命科學(xué)試劑-MedChemExpress_第2頁(yè)
Tedizolid-phosphate-TR-701FA-DataSheet-生命科學(xué)試劑-MedChemExpress_第3頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemETedizolid phosphateCat. No.: HY-14855BCAS No.: 856867-55-5Synonyms: TR-701FA分式: CHFNOP分量: 450.32作靶點(diǎn): Bacterial作通路: Anti-infection儲(chǔ)存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 36 mg/mL (79

2、.94 mM)H2O : 0.1 mg/mL (0.22 mM; Need ultrasonic)* means soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制備儲(chǔ)備液1 mM 2.2206 mL 11.1032 mL 22.2064 mL5 mM 0.4441 mL 2.2206 mL 4.4413 mL10 mM 0.2221 mL 1.1103 mL 2.2206 mL請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲(chǔ)備液,并請(qǐng)注意儲(chǔ)備液的保存式和期限。BIOLOGICAL ACTIV

3、ITY物活性 Torezolid磷酸鹽MAO-A和MAO-B抑制劑,具有抗蘭陽(yáng)性菌的活性。體外研究 Tedizolid (0.25 g/mL) inhibits all 28 clinical isolates of PRSP, and is 4-fold more potent than linezolid againstPRSP 1.1/2 Master of Small Molecules 您邊的抑制劑師www.MedChemE體內(nèi)研究 For mice infected with PSSP type III, the 100% survival rate is achieved wit

4、h tedizolid phosphate at aminimum total daily dose of 10 mg/kg. Lungs of infected mice treated with tedizolid phosphate show lesssevere inflammation and edema, as indicated by the mean scores for inflammation and edema 1.PROTOCOLAnimal To induce a systemic S. pneumoniae infection, male ICR mice (wei

5、ght, 18 to 20 g) are inoculatedAdministration 1 intraperitoneally with 1 of 4 PRSP isolates (DR9, DR10, DR11, or DR14) suspended in 10% mucin. Thesuspension contained sufficient bacteria to kill 100% of untreated control mice. At 1 h postinfection, micereceives a single dose of either tedizolid phos

6、phate or linezolid, and survival is assessed daily for 7 dayspostinfection. Treatments are delivered both orally and intravenously at each of four doses (40 mg/kg of bodyweight, 13.33 mg/kg, 4.44 mg/kg, and 1.48 mg/kg), with 8 mice per group defined by dose, delivery method,and infecting strain. The

7、 50% effective dose (ED50), i.e., the dose allowing survival of 50% of the infectedmice, is calculated for each delivery route using probit analysis.MCE has not independently confirmed the accuracy of these methods. They are for reference only.戶使本產(chǎn)品發(fā)表的科研獻(xiàn) Front Microbiol. 2018 Sep 7;9:2095. J Pharm

8、Biomed Anal. 2019 May 30;169:170-180. J Pharm Biomed Anal. 2017 May 30;139:221-231. J Pharm Biomed Anal. 2016 Feb 20;120:402-12. Journal of Molecular Structure. 2016 Jul 5; 1115:136-143.See more customer validations on HYPERLINK / www.MedChemEREFERENCES1. Choi S, et al. Activity of Tedizolid Phosphate (TR-701) in Murine Models of Infection with Penicillin-resistant and Penicillin-sensitiveStreptococcus pneumoniae. Antimicrob Agents Chemother. 2012 Jun 19.McePdfHeightCaution: Product has not been fully validated for medical appl

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論